Treatment of Persistent Perceptual Postural Dizziness (PPPD)
The most effective treatment for persistent perceptual postural dizziness (PPPD) is a combination of vestibular rehabilitation therapy (VRT) with cognitive-behavioral therapy (CBT), potentially augmented with serotonergic medications. 1, 2
Understanding PPPD
PPPD is a functional vestibular disorder characterized by:
- Persistent dizziness or unsteadiness occurring on most days for more than 3 months
- Symptoms exacerbated by upright posture, active or passive motion, and visual stimuli
- Often develops following a triggering event (vestibular disorder, medical condition, or psychological stressor)
Treatment Approach
First-Line Treatment: Vestibular Rehabilitation Therapy (VRT)
VRT has been shown to significantly improve quality of life, dizziness handicap, depression, and anxiety levels within 3 months in PPPD patients 3. The effectiveness of VRT includes:
- Home-based VRT programs are as effective as hospital-based programs 3
- Customized VRT exercises targeting specific symptoms
- Habituation exercises to reduce sensitivity to movement and visual stimuli
- Balance retraining to improve postural control
- Gaze stabilization exercises
VRT should be personalized to address the specific triggers and symptoms of the individual patient, with gradual progression in exercise difficulty 4.
Second-Line Treatment: Cognitive-Behavioral Therapy (CBT)
CBT should be integrated with VRT for optimal outcomes 1, 2. The INVEST trial demonstrated promising benefits of CBT-informed vestibular rehabilitation compared to standard VRT alone 2. CBT components include:
- Addressing maladaptive thoughts and behaviors related to dizziness
- Reducing symptom hypervigilance and catastrophizing
- Exposure therapy to feared movements or environments
- Anxiety management techniques
- Behavioral activation to reduce avoidance behaviors
Pharmacological Treatment
Serotonergic medications may facilitate rehabilitation in PPPD 1, although evidence level is low:
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
- Start with low doses and gradually increase to minimize side effects
- Allow 4-6 weeks for therapeutic effect
Treatment Algorithm
Initial Phase (Weeks 1-4):
- Begin customized VRT program focusing on habituation exercises
- Introduce basic CBT concepts to address anxiety and avoidance behaviors
- Consider starting low-dose SSRI if significant anxiety/depression present
Intermediate Phase (Weeks 5-8):
- Progress VRT exercises in complexity and duration
- Intensify CBT interventions focusing on exposure therapy
- Adjust medication dosage if needed
Advanced Phase (Weeks 9-12):
- Challenge patient with more complex VRT exercises
- Focus CBT on relapse prevention strategies
- Assess medication effectiveness and continue if beneficial
Monitoring Treatment Response
Evaluate treatment effectiveness using validated assessment tools:
- Dizziness Handicap Inventory (DHI)
- Depression, Anxiety and Stress Scale (DASS-21)
- Quality of life measures (EQ-5D)
Important Considerations and Pitfalls
- Rule out organic causes: Before diagnosing PPPD, ensure thorough evaluation to exclude central vertigo or other neurological disorders 5
- Treatment resistance factors: Patients with longer duration of PPPD, complex aggravating factors, and higher initial DHI scores may have poorer response to VRT 4
- Recurrence risk: Similar to BPPV, PPPD may have recurrences requiring ongoing management strategies 5
- Elderly patients: May require modified approaches with gentler progression of exercises and careful medication management 5
Patient Education
Patient education is crucial for treatment success:
- Explain the functional nature of PPPD without dismissing symptoms
- Emphasize that PPPD is a real condition with effective treatments
- Set realistic expectations about treatment timeline (typically 3 months)
- Encourage adherence to home exercises and CBT techniques
By implementing this comprehensive approach, most patients with PPPD can experience significant improvement in symptoms and quality of life.